| Literature DB >> 23870629 |
A Menrath1, K Tomuzia, H Frentzel, J Braeunig, B Appel.
Abstract
Strong efforts are made to improve preparedness for the prevention and counteraction of possible deliberate release of highly pathogenic biological agents at national and international level. An objective risk assessment for highly pathogenic biological agents is urgently needed for the purpose of prioritizing measures, evaluating the vulnerabilities and supporting rapid decisions on a scientific base in case of an emergency. Hitherto, several differing ranking schemes were developed. In general, the purpose of such ranking schemes is a comparative classification of agents under consideration of different transmission paths as well as agents threatening human and/or animal health. The analysed prioritization methods differ from qualitative to (semi-)quantitative with each its benefits and disadvantages in preciseness of the result, complexity and duration of the assessment but also in comprehensibility. Mainly, risk was defined as the product of probability and impact. In this survey, factors frequently used for the assessment of the probability and impact of a deliberate agent release were identified. Main criteria for the probability of an application were the history of use, the accessibility of the agent and possible paths of introduction and contamination as well as the feasibility of agent production. For the estimation of the impact, mainly the agent's effects on human and/or veterinary public health, depending on the target population, were examined. This includes the morbidity and mortality rates as well as the severity of induced illness, possible measures for diagnosis, and treatment and prevention. Furthermore, the economic and socioeconomic consequences were considered. In this review, the authors give an overview on open-source publications dealing with risk ranking of biological agents by outlining the criteria that were applied for risk ranking.Entities:
Keywords: Risk assessment; bioterrorism; categorization; high-risk biological agents; prioritization; zoonoses
Mesh:
Substances:
Year: 2013 PMID: 23870629 PMCID: PMC4171777 DOI: 10.1111/zph.12065
Source DB: PubMed Journal: Zoonoses Public Health ISSN: 1863-1959 Impact factor: 2.702
Surveyed literature, listed in alphabetical order of sources
| Reference | Focus | Risk Assessment Method | Structure of Agent List |
|---|---|---|---|
| Ackermann and Moran ( | General | Qualitative (theoretical) | – |
| Animal and Plant Health Inspection Service, USDA (Anon, | Animal | Qualitative (probably; based on expert panel) | 2 tiers |
| Anonymous ( | Human | Unknown (probably qualitative) | Unranked |
| Australia Group ( | Animal | Qualitative (expert opinion) | Unranked |
| Australia Group ( | Human | Qualitative (expert opinion) | Unranked |
| Capek ( | General | Semiquantitative | 3 tiers |
| Cardoen et al. ( | Human | Semiquantitative (based on expert, opinion, experts were equipped with fact sheets), weighting factors | Quantitative (integer scores between 0 and 20 possible) |
| Centers for Disease Control and Prevention (CDC) ( | Human | Semiquantitative | 3 tiers |
| Codex Alimentarius Commission ( | Food | Theoretical | – |
| Davis ( | Animal | Qualitative | Unranked |
| Department for Environment Food and Rural Affairs (DEFRA/UK) ( | Animal | Semiquantitative (theoretical) | – |
| Doherty et al. ( | Human | Semiquantitative | Unranked |
| Elad ( | Food | Theoretical | – |
| European Commission: DG SANCO ( | Human | Unknown (probably qualitative) | 2 tiers |
| European Technology Platform for Global Animal Health ( | Animal | Semiquantitative (theoretical) | – |
| Federal Ministry of Food Agriculture and Consumer Protection/Germany ( | Food | Qualitative | 3 tiers |
| Federal Office of Public Health/Switzerland ( | Food | Semiquantitative | 5 tiers |
| Franz et al. ( | Human | Qualitative | Unranked |
| Havelaar et al. ( | Human | Semiquantitative | Quantitative (scores between 0 and 1 possible) |
| Irlenkäuser ( | Animal | Qualitative | Unranked |
| Krause ( | Human | Semiquantitative by experts | – |
| Lele ( | Human | Theoretical | – |
| MacIntyre et al. ( | Human | Semiquantitative | Quantitative (all integer scores between 0 and 20 possible) |
| NATO -Departments of the Army, the Navy andthe Air Force/USA (Anon, | Human | Qualitative (theoretical) | – |
| Okelo and Food and Drug Administration/USA (FDA) ( | Feed | Quantitative (with exponential range; theoretical) | – |
| Panel on Biological Hazards (BIOHAZ) ( | Feed | Qualitative/unknown | – |
| Pappas et al. ( | Human | Semiquantitative | Quantitative (all integer scores between 0 and 30 possible) |
| Radosavljevic and Belojevic ( | Human | Semiquantitative (theoretical) | – |
| Salerno et al. ( | Human | Theoretical | – |
| Tegnell et al. ( | Human | Semiquantitative | 5 tiers |
| Wheelis ( | Animal | Theoretical | – |
| World Health Organization (WHO) ( | Human | Semiquantitative (by experts) | Quantitative |
| World Organization of Animal Health (OIE) ( | Animal | Qualitative | 2 tiers |
| World Organization for Animal Health (OIE) ( | Animal | Qualitative | Unranked |
Theoretical: criteria were listed without the generation of a list of relevant pathogens. Qualitative: criteria were considered (by the authors or other experts) and are the basis of a list of relevant agents (subjective). Semiquantitative: used criteria take values that are ordinal-scaled integer numbers. These numbers are, summed or multiplied and in parts also weighted, the basis for a list of relevant biological agents. Quantitative: used criteria take all metric positive values. These numbers are, summed or multiplied and in parts also weighted, the basis for a list of relevant biological agents.
Quantitative: all metric positive values are possible for the selected biological agents (sometimes the number of values is somewhat restricted). Unranked: formation of a list of threatening agents without comparative graduation within the list.
Aspects considered for risk assessment of biological agents in literature of Table 1
| • Criterion | ||
|---|---|---|
| Category | ○ Measure | |
| Probability | History of use (MacIntyre et al., | • Former attacks in example function |
| Probability | Availability/Accessibility of the agent (Anon, | • Number of laboratories possessing the agent |
| • Prevalence in humans per year | ||
| • BSL level | ||
| • Prevalence of the agent in the environment | ||
| Probability | Feasibility of reproduction (Anon, | • Production efforts (organizational, financial) |
| • Large-scale production possibility | ||
| • Storage life (duration of toxicity/infectivity under optimal circumstances) | ||
| Probability | Agent dispersion (Anon, | • Paths for dispersion of the agent (food, feeding stuff, aerosol, water, animated and inanimated vectors) |
| • Survival in the environment | ||
| • Weaponizability | ||
| Impact | Human and Veterinary Public Health (Anon, | • Case-fatality rate |
| • Morbidity rate | ||
| • Severity of disease | ||
| ○ Course of disease | ||
| ○ Main affected organ system | ||
| ○ Infectious dose/LD 50 | ||
| • Time of incubation | ||
| • Duration of illness | ||
| • Risk rate for complications | ||
| • Individuals susceptible in the EU (existence of YOPI) | ||
| • Capacity in medical facilities (human) | ||
| ○ Type of treatment needed | ||
| • Transmission paths | ||
| ○ Type of transmission | ||
| ○ Zoonotic disease (human) | ||
| ○ Potential for inter-species transmission (animals) | ||
| Impact | Countermeasures (Anon, | • Treatment in humans (availability of medicine) |
| • Containment in humans (availability of vaccines) | ||
| • Containment of the outbreak [necessary disaster management efforts (e.g.: disinfection)] | ||
| Impact | Diagnostics (Anon, | • Detection of agent in the matrix |
| ○ Perception by senses | ||
| ○ Prescribed surveillance in food | ||
| ○ Prescribed surveillance in feed | ||
| ○ Detection systems for food of animal origin | ||
| ○ Detection systems for feeds | ||
| • Diagnostic detection in the population | ||
| ○ Communicability of disease | ||
| ○ Detection system for patient samples | ||
| ○ Commercial kits available | ||
| Impact | Economic and socioeconomic losses (Anon, | • Containment of the outbreak in animals (availability of vaccines) |
| • Economic loss (costs of treatment if available) | ||
| ○ Loss of productivity through animal diseases | ||
| ○ Culling of animals | ||
| ○ Trade restrictions | ||
| • Socioeconomic losses | ||
| ○ Calculation by DALY (disability-adjusted life years) | ||
| • Ecological damage | ||
| Impact | Public perception (Ackermann and Moran, | • Public panic potential |